Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "labs"

458 News Found

New England Biolabs unveils high-speed flu sequencing tool to bolster global outbreak surveillance
R&D | November 18, 2025

New England Biolabs unveils high-speed flu sequencing tool to bolster global outbreak surveillance

Developed in partnership with the Johns Hopkins Applied Physics Laboratory (APL), the module is built around a multi-segment RT-PCR method with integrated indexing


UK MHRA finds gut microbiome research unreliable across labs
R&D | November 14, 2025

UK MHRA finds gut microbiome research unreliable across labs

False positive rates?ranged from 0% to 41%, meaning some labs incorrectly identified bacteria that weren’t present in the sample


Dr Lal Path Labs reports consolidated Q2 FY26 PAT at Rs. 150.6 Cr
News | November 02, 2025

Dr Lal Path Labs reports consolidated Q2 FY26 PAT at Rs. 150.6 Cr

The company has posted net profit of Rs. 283 crore for the 6 months period ended September 30, 2025


Laurus Labs posts Q2 FY26 consolidated PAT higher at Rs. 195 Cr
News | October 24, 2025

Laurus Labs posts Q2 FY26 consolidated PAT higher at Rs. 195 Cr

Laurus Labs has reported total income of Rs. 1,680.43 crore during the period ended September 30, 2025


BioMed X launches women’s health R&D accelerator ‘XFem labs’ in Germany
R&D | October 14, 2025

BioMed X launches women’s health R&D accelerator ‘XFem labs’ in Germany

First research project, supported by the Gates Foundation, focuses on developing non-hormonal contraceptives for women in low- and middle-income countries


Aarti Pharmalabs inaugurates phase 1 of greenfield manufacturing facility
News | September 04, 2025

Aarti Pharmalabs inaugurates phase 1 of greenfield manufacturing facility

Phase 1 has a total reactor capacity of 440 kL with 63 reactors


Dr. Lal PathLabs pioneers AI integration in cancer diagnosis in India
Digitisation | August 21, 2025

Dr. Lal PathLabs pioneers AI integration in cancer diagnosis in India

The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases


BioAge Labs doses first patient in BGE-102 phase 1 trial
Biotech | August 19, 2025

BioAge Labs doses first patient in BGE-102 phase 1 trial

The randomized, double-blind, placebo-controlled Phase 1 study is designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102 in healthy participants


Laurus Labs allotted 531.77 acres of land by the Govt. of Andhra Pradesh
News | July 28, 2025

Laurus Labs allotted 531.77 acres of land by the Govt. of Andhra Pradesh

The company has projected Rs. 5,630 crores of investment and to provide employment to 6,350 people in three phases over a period of eight years


Laurus Labs to invest €5 million in JV KRKA Pharma
News | July 27, 2025

Laurus Labs to invest €5 million in JV KRKA Pharma

The purpose of this investment is to meet the expenditure relating to the civil works to be undertaken for setting up of a manufacturing facility